Ground-Breaking Web Platform Revolutionizes Biomedical Research

Ground-Breaking Web Platform Revolutionizes Biomedical Research

TORONTO, July 6, 2010--

    - BioHub-Online.org to Slash $1 Billion in Wasted Research Funds Through
Community Networking

    BioHub Inc., announced today the launch of BioHub-Online.org, a first-of-
its-kind online platform to facilitate global networking and collaboration
among research scientists.

    Antibodies are biomedical research reagents used for hundreds of
thousands of experiments globally. The global market for research
antibodies exceeds $2 billion, yet independent studies show that less than
50% of commercial antibodies are of adequate quality, leading to
compromised results and wasted time and resources. Developed to respond to
this problem, BioHub-Online.org is a web-based networking tool that not
only serves as a comprehensive listing of over 100,000 antibody products,
but also provides researchers with the opportunity to provide product
reviews. Taken together, BioHub-Online.org will allow scientists to make
informed decisions, thus increasing the efficiency of biomedical research.

    Motivated to advocate product excellence and transparency within the
biomedical marketplace, Alex Hodgson, co-founder of BioHub remarked, "We as
a community need to support those companies who go that extra mile to bring
us top-quality products and hold those that don't accountable."

    BioHub-Online.org has already won the support of leading researchers,
including Dr. Aled Edwards (Structural Genomics Consortium), Dr. Sachdev
Sidhu (University of Toronto), Dr. Brian Marsden (University of Oxford) and
Dr. Lori Frappier (Canada Research Chair in Virology). "Antibodies are
among the most commonly used reagents in biomedicine, yet are subjected to
the least effective quality control. BioHub will create order from this
chaos by empowering the scientific community to communicate their reviews
of commercial products," says Dr. Aled Edwards.

    BioHub promises to not only create a channel of direct feedback
between scientists and antibody providers, but also creates opportunities
for users to connect with each other. Two of BioHub's community features
include: BioAlerts, which lets users know when new antibodies and data have
been uploaded for specific targets, while BioMessenger enables users to
send direct messages to other users to facilitate follow-on collaborations.

    About BioHub, Inc.

    BioHub, Inc. is a privately owned Canadian corporation that operates
BioHub-Online.org, an open-access online platform designed to meet the
needs of the biomedical research community. BioHub enables users to connect
with colleagues, discover which products work best for specific
applications, share experiences and collaborate online.

    For additional information on BioHub-Online.org, contact Alex Hodgson
(+1-647-981-2461/alex@biohub-online.org) or visit
http://www.biohub-online.org.

    For further information: Alexandra Hodgson, 117-112 College Street,
Toronto, ON, Canada, M5G 1L6, Email: alex@biohub-online.org, Tel:
+1-647-981-2461

Source: BioHub, Inc.

For further information: Alexandra Hodgson, 117-112 College Street, Toronto, ON, Canada, M5G 1L6, Email: alex@biohub-online.org, Tel: +1-647-981-2461